Bioxcel Therapeutics Stock Price History
| BTAI Stock | USD 2.33 0.03 1.27% |
Below is the normalized historical share price chart for BioXcel Therapeutics extending back to March 08, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BioXcel Therapeutics stands at 2.33, as last reported on the 21st of March, with the highest price reaching 2.33 and the lowest price hitting 2.33 during the day.
If you're considering investing in BioXcel Stock, it is important to understand the factors that can impact its price. BioXcel Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0301, which signifies that the company had a -0.0301 % return per unit of risk over the last 3 months. BioXcel Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioXcel Therapeutics' Mean Deviation of 8.65, risk adjusted performance of (0.03), and Standard Deviation of 14.42 to double-check the risk estimate we provide.
As of now, BioXcel Therapeutics' Other Stockholder Equity is increasing as compared to previous years. The BioXcel Therapeutics' current Liabilities And Stockholders Equity is estimated to increase to about 112.8 M, while Total Stockholder Equity is forecasted to increase to (61.7 M). . The current Price To Sales Ratio is estimated to decrease to 1,088. The current Price Earnings Ratio is estimated to decrease to -7.26. BioXcel Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of March 2018 | 200 Day MA 10.2312 | 50 Day MA 3.8663 | Beta 0.898 |
BioXcel |
Sharpe Ratio = -0.0301
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BTAI |
Estimated Market Risk
| 14.97 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.45 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BioXcel Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioXcel Therapeutics by adding BioXcel Therapeutics to a well-diversified portfolio.
Price Book 3.9656 | Enterprise Value Ebitda (0.75) | Price Sales 3.5342 | Shares Float 2 M | Wall Street Target Price 37 |
BioXcel Therapeutics Stock Price History Chart
There are several ways to analyze BioXcel Stock price data. The simplest method is using a basic BioXcel candlestick price chart, which shows BioXcel Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 6, 2025 | 9.17 |
| Lowest Price | February 27, 2025 | 1.73 |
BioXcel Therapeutics March 21, 2025 Stock Price Synopsis
Various analyses of BioXcel Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell BioXcel Stock. It can be used to describe the percentage change in the price of BioXcel Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of BioXcel Stock.| BioXcel Therapeutics Price Rate Of Daily Change | 0.99 | |
| BioXcel Therapeutics Price Action Indicator | (0.01) |
BioXcel Therapeutics March 21, 2025 Stock Price Analysis
BioXcel Stock Price History Data
The price series of BioXcel Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 7.44 with a coefficient of variation of 42.1. The prices are distributed with arithmetic mean of 4.4. The median price for the last 90 days is 5.17. The company had 1:16 stock split on 10th of February 2025.| Open | High | Low | Close | Volume | ||
03/21/2025 | 2.36 | 2.33 | 2.33 | 2.33 | ||
| 03/20/2025 | 2.37 | 2.38 | 2.12 | 2.36 | 503,491 | |
| 03/19/2025 | 2.37 | 3.11 | 2.25 | 2.37 | 4,196,501 | |
| 03/18/2025 | 2.19 | 2.26 | 2.04 | 2.20 | 230,042 | |
| 03/17/2025 | 2.07 | 2.40 | 2.07 | 2.28 | 180,760 | |
| 03/14/2025 | 2.33 | 2.38 | 1.99 | 2.13 | 340,782 | |
| 03/13/2025 | 2.33 | 2.42 | 2.16 | 2.25 | 205,058 | |
| 03/12/2025 | 2.52 | 2.60 | 2.34 | 2.43 | 279,428 | |
| 03/11/2025 | 3.07 | 3.15 | 2.25 | 2.47 | 1,187,083 | |
| 03/10/2025 | 3.27 | 3.85 | 2.92 | 2.97 | 1,472,912 | |
| 03/07/2025 | 2.75 | 3.44 | 2.68 | 3.37 | 2,507,040 | |
| 03/06/2025 | 2.66 | 3.08 | 2.44 | 2.74 | 1,121,174 | |
| 03/05/2025 | 3.18 | 3.36 | 2.73 | 2.73 | 10,107,303 | |
| 03/04/2025 | 3.50 | 3.50 | 2.52 | 2.70 | 2,277,618 | |
| 03/03/2025 | 2.40 | 6.83 | 2.37 | 3.75 | 146,836,977 | |
| 02/28/2025 | 1.95 | 2.82 | 1.82 | 2.16 | 102,419,828 | |
| 02/27/2025 | 1.80 | 1.93 | 1.72 | 1.73 | 81,354 | |
| 02/26/2025 | 1.80 | 1.89 | 1.79 | 1.80 | 50,352 | |
| 02/25/2025 | 2.00 | 2.02 | 1.75 | 1.80 | 146,755 | |
| 02/24/2025 | 2.14 | 2.19 | 1.93 | 1.97 | 127,148 | |
| 02/21/2025 | 2.27 | 2.30 | 2.10 | 2.13 | 122,920 | |
| 02/20/2025 | 2.40 | 2.47 | 2.25 | 2.30 | 89,172 | |
| 02/19/2025 | 2.27 | 2.60 | 2.27 | 2.38 | 240,051 | |
| 02/18/2025 | 2.39 | 2.39 | 2.18 | 2.27 | 116,350 | |
| 02/14/2025 | 2.36 | 2.50 | 2.30 | 2.31 | 131,434 | |
| 02/13/2025 | 2.80 | 2.80 | 2.16 | 2.38 | 348,204 | |
| 02/12/2025 | 2.55 | 2.84 | 2.50 | 2.81 | 158,780 | |
| 02/11/2025 | 2.93 | 2.93 | 2.51 | 2.55 | 230,256 | |
| 02/10/2025 | 2.82 | 3.15 | 2.74 | 2.98 | 392,277 | |
| 02/07/2025 | 3.10 | 3.12 | 2.56 | 2.64 | 283,317 | |
| 02/06/2025 | 3.68 | 3.82 | 2.94 | 2.99 | 613,068 | |
| 02/05/2025 | 4.80 | 4.88 | 4.26 | 4.78 | 258,855 | |
| 02/04/2025 | 4.80 | 5.28 | 4.54 | 4.56 | 134,663 | |
| 02/03/2025 | 4.93 | 5.12 | 4.67 | 4.92 | 90,886 | |
| 01/31/2025 | 5.20 | 5.41 | 5.05 | 5.22 | 33,899 | |
| 01/30/2025 | 5.12 | 5.44 | 4.75 | 5.17 | 129,427 | |
| 01/29/2025 | 5.42 | 5.58 | 5.26 | 5.28 | 53,793 | |
| 01/28/2025 | 5.57 | 5.62 | 5.15 | 5.50 | 74,052 | |
| 01/27/2025 | 5.28 | 5.96 | 5.04 | 5.85 | 178,035 | |
| 01/24/2025 | 6.44 | 6.99 | 5.44 | 5.44 | 1,909,220 | |
| 01/23/2025 | 5.77 | 6.14 | 5.49 | 6.08 | 152,449 | |
| 01/22/2025 | 5.68 | 6.69 | 5.45 | 5.82 | 196,092 | |
| 01/21/2025 | 5.46 | 5.86 | 5.44 | 5.73 | 48,330 | |
| 01/17/2025 | 5.60 | 5.74 | 5.20 | 5.50 | 56,001 | |
| 01/16/2025 | 5.60 | 5.74 | 5.33 | 5.53 | 23,081 | |
| 01/15/2025 | 5.71 | 5.79 | 5.30 | 5.54 | 56,374 | |
| 01/14/2025 | 6.24 | 6.30 | 5.60 | 5.71 | 37,981 | |
| 01/13/2025 | 5.63 | 6.14 | 5.12 | 6.14 | 74,759 | |
| 01/10/2025 | 5.92 | 6.13 | 5.62 | 6.04 | 52,068 | |
| 01/08/2025 | 7.40 | 7.49 | 6.01 | 6.17 | 107,433 | |
| 01/07/2025 | 9.12 | 9.14 | 6.93 | 7.54 | 114,488 | |
| 01/06/2025 | 6.72 | 9.26 | 6.70 | 9.17 | 403,622 | |
| 01/03/2025 | 6.56 | 6.64 | 6.28 | 6.62 | 35,583 | |
| 01/02/2025 | 6.16 | 6.69 | 6.08 | 6.27 | 41,279 | |
| 12/31/2024 | 5.92 | 6.40 | 5.77 | 5.98 | 53,062 | |
| 12/30/2024 | 6.72 | 6.72 | 5.60 | 5.87 | 78,720 | |
| 12/27/2024 | 6.08 | 7.04 | 5.95 | 6.30 | 113,892 | |
| 12/26/2024 | 5.60 | 6.39 | 5.28 | 5.95 | 110,019 | |
| 12/24/2024 | 5.44 | 5.71 | 5.23 | 5.62 | 26,249 | |
| 12/23/2024 | 5.46 | 5.73 | 5.06 | 5.54 | 43,933 | |
| 12/20/2024 | 4.83 | 5.51 | 4.80 | 5.46 | 51,598 |
About BioXcel Therapeutics Stock history
BioXcel Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioXcel is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioXcel Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioXcel Therapeutics stock prices may prove useful in developing a viable investing in BioXcel Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 33.5 M | 21.5 M | |
| Net Loss | -149.2 M | -141.7 M |
BioXcel Therapeutics Quarterly Net Working Capital |
|
BioXcel Therapeutics Stock Technical Analysis
BioXcel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
BioXcel Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BioXcel Therapeutics' price direction in advance. Along with the technical and fundamental analysis of BioXcel Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioXcel to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.58) | |||
| Total Risk Alpha | 0.5159 | |||
| Treynor Ratio | (0.44) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for BioXcel Stock analysis
When running BioXcel Therapeutics' price analysis, check to measure BioXcel Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioXcel Therapeutics is operating at the current time. Most of BioXcel Therapeutics' value examination focuses on studying past and present price action to predict the probability of BioXcel Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioXcel Therapeutics' price. Additionally, you may evaluate how the addition of BioXcel Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |